Effect of mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms

British Journal of Pharmacology

Volumn 170, Issue 5, 2013, Pages 1027-1040

  Jiang, Jianping ^a   Wang, Dongmei ^a   Zhou, Xiaolong ^a   Huo, Yuping ^a   Chen, Tingjun ^a   Hu, Fenjuan ^a   Quirion, Rémi ^b   Hong, Yanguo ^a  

^a FUJIAN NORMAL UNIVERSITY   (China)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

opioidergic activity; dorsal root ganglia (DRG); inflammatory hyperalgesia; Mas related gene (Mrg) receptors; spinal dorsal horn

Indexed keywords

BETA ENDORPHIN; CALCITONIN GENE RELATED PEPTIDE; FREUND ADJUVANT; G PROTEIN COUPLED RECEPTOR; MAS ONCOGENE RELATED GENE RECEPTOR; MESSENGER RNA; MU OPIATE RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; PROOPIOMELANOCORTIN; PROTEIN C FOS; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERALGESIA; IMMUNOCYTOCHEMISTRY; INFLAMMATORY PAIN; LUMBAR SPINE; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD DORSAL HORN; SPINAL GANGLION; UPREGULATION; WESTERN BLOTTING;

DORSAL ROOT GANGLIA (DRG); INFLAMMATORY HYPERALGESIA; MAS-RELATED GENE (MRG) RECEPTORS; SPINAL DORSAL HORN; Μ-OPIOIDERGIC ACTIVITY;

ANALGESICS; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; FREUND'S ADJUVANT; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HYPERALGESIA; INFLAMMATION; MALE; MELANOCYTE-STIMULATING HORMONES; NARCOTIC ANTAGONISTS; NITRIC OXIDE SYNTHASE TYPE I; PAIN THRESHOLD; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOMATOSTATIN; TIME FACTORS;

EID: 84885649223     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12326     Document Type: Article

References (61)

1. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-324
2. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. (2008). Opioid complications and side effects. Pain Physician 11: S105-S120.
3. Boettger MK, Uceyler N, Zelenka M, Schmitt A, Reif A, Chen Y, et al. (2007). Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain 11: 810-818.
4. Burstein ES, Ott TR, Feddock M, Ma JN, Fuhs S, Wong S, et al. (2006). Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors. Br J Pharmacol 147: 73-82.
5. Cabot PJ, Carter L, Schafer M, Stein C, (2001). Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 93: 207-212.
6. Cai M, Chen T, Quirion R, Hong Y, (2007a). The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing. Eur J Neurosci 26: 1128-1138.
7. Cai Q, Jiang J, Chen T, Hong Y, (2007b). Sensory neuron-specific receptor agonist BAM8-22 inhibits the development and expression of tolerance to morphine in rats. Behav Brain Res 178: 154-159.
8. Chen T, Cai Q, Hong Y, (2006). Intrathecal sensory neuron-specific receptor agonists bovine adrenal medulla 8-22 and (tyr(6))-gamma2-msh-6-12 inhibit formalin-evoked nociception and neuronal fos-like immunoreactivity in the spinal cord of the rat. Neuroscience 141: 965-975.
9. Chen T, Hu Z, Quirion R, Hong Y, (2008). Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22. Neuropharmacology 54: 796-803.
10. Choi SS, Lahn BT, (2003). Adaptive evolution of MRG, a neuron-specific gene family implicated in nociception. Genome Res 13: 2252-2259.
11. Chu YC, Guan Y, Skinner J, Raja SN, Johns RA, Tao YX, (2005). Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain 119: 113-123.
12. Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ, (2001). A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106: 619-632.
13. Fehrenbacher JC, Taylor CP, Vasko MR, (2003). Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105: 133-141.
14. Galeazza MT, Garry MG, Yost HJ, Strait KA, Hargreaves KM, Seybold VS, (1995). Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation. Neuroscience 66: 443-458.
15. Garry MG, Walton LP, Davis MA, (2000). Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP. Brain Res 861: 208-219.
16. Grazzini E, Puma C, Roy MO, Yu XH, O'Donnell D, Schmidt R, et al. (2004). Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats. Proc Natl Acad Sci U S A 101: 7175-7180.
17. Guan Y, Liu Q, Tang Z, Raja SN, Anderson DJ, Dong X, (2010). Mas-related G-protein-coupled receptors inhibit pathological pain in mice. Proc Natl Acad Sci U S A 107: 15933-15938.
18. Han SK, Dong X, Hwang JI, Zylka MJ, Anderson DJ, Simon MI, (2002). Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway. Proc Natl Acad Sci U S A 99: 14740-14745.
19. Harris JA, (1998). Using c-fos as a neural marker of pain. Brain Res Bull 45: 1-8.
20. Hong Y, Liu Y, Chabot JG, Fournier A, Quirion R, (2009). Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats. Pain 146: 105-113.
21. Hong Y, Jiang J, Chen T, Wang D, Huo Y, Zhang W, et al. (2012). Intrathecal administration of the MrgC receptor agonist BAM8-22 or MSH inhibits CFA-induced hyperalgesia via suppression of nNOS and CGRP as well as recruiting endogenous μ-opioid action in rats. The 14th World Congress of Pain Stud, 12516.
22. Hsieh GC, Pai M, Chandran P, Hooker BA, Zhu CZ, Salyers AK, et al. (2011). Central and peripheral sites of action for CB receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Br J Pharmacol 162: 428-440.
23. Katsuyama S, Mizoguchi H, Kuwahata H, Komatsu T, Nagaoka K, Nakamura H, et al. (2013). Involvement of peripheral cannabinoid and opioid receptors in beta-caryophyllene-induced antinociception. Eur J Pain 17: 664-675.
24. Kawamura M, Kuraishi Y, Minami M, Satoh M, (1989). Antinociceptive effect of intrathecally administered antiserum against calcitonin gene-related peptide on thermal and mechanical noxious stimuli in experimental hyperalgesic rats. Brain Res 497: 199-203.
25. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: The ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
26. Kuraishi Y, Nanayama T, Ohno H, Minami M, Satoh M, (1988). Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci Lett 92: 325-329.
27. Lembo PM, Grazzini E, Groblewski T, O'Donnell D, Roy MO, Zhang J, et al. (2002). Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat Neurosci 5: 201-209.
28. Liu Q, Tang Z, Surdenikova L, Kim S, Pate KN, Kim A, et al. (2009). Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139: 1353-1365.
29. Malcangio M, Bowery NG, (1994). Spinal cord SP release and hyperalgesia in monoarthritic rats: involvement of the GABAB receptor system. Br J Pharmacol 113: 1561-1566.
30. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
31. Meller ST, Cummings CP, Traub RJ, Gebhart GF, (1994). The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 60: 367-374.
32. Miletic V, Tan H, (1988). Iontophoretic application of calcitonin gene-related peptide produces a slow and prolonged excitation of neurons in the cat lumbar dorsal horn. Brain Res 446: 169-172.
33. Nahin RL, Byers MR, (1994). Adjuvant-induced inflammation of rat paw is associated with altered calcitonin gene-related peptide immunoreactivity within cell bodies and peripheral endings of primary afferent neurons. J Comp Neurol 349: 475-485.
34. Nahin RL, Hylden JL, Iadarola MJ, Dubner R, (1989). Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord. Neurosci Lett 96: 247-252.
35. Ndong C, Pradhan A, Puma C, Morello JP, Hoffert C, Groblewski T, et al. (2009). Role of rat sensory neuron-specific receptor (rSNSR1) in inflammatory pain: contribution of TRPV1 to SNSR signaling in the pain pathway. Pain 143: 130-137.
36. Negrete R, Hervera A, Leanez S, Martin-Campos JM, Pol O, (2011). The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids. PLoS One 6: e26688.
37. Neugebauer V, Rumenapp P, Schaible HG, (1996). Calcitonin gene-related peptide is involved in the spinal processing of mechanosensory input from the rat's knee joint and in the generation and maintenance of hyperexcitability of dorsal horn-neurons during development of acute inflammation. Neuroscience 71: 1095-1109.
38. Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, Przewlocka B, et al. (2009). Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141: 283-291.
39. Parolaro D, Rubino T, Vigano D, Massi P, Guidali C, Realini N, (2010). Cellular mechanisms underlying the interaction between cannabinoid and opioid system. Curr Drug Targets 11: 393-405.
40. Pelton JT, Gulya K, Hruby VJ, Duckles SP, Yamamura HI, (1985). Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity. Proc Natl Acad Sci U S A 82: 236-239.
41. Pogatzki EM, Zahn PK, Brennan TJ, (2000). Lumbar catheterization of the subarachnoid space with a 32-gauge polyurethane catheter in the rat. Eur J Pain 4: 111-113.
42. Pozza M, Bettelli C, Magnani F, Mascia MT, Manzini E, Calza L, (1998). Is neuronal nitric oxide involved in adjuvant-induced joint inflammation? Eur J Pharmacol 359: 87-93.
43. Puehler W, Zollner C, Brack A, Shaqura MA, Krause H, Schafer M, et al. (2004). Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129: 473-479.
44. Rittner HL, Brack A, Stein C, (2008). Pain and the immune system. Br J Anaesth 101: 40-44.
45. Russo R, D'Agostino G, Mattace RG, Avagliano C, Cristiano C, Meli R, et al. (2012). Central administration of oxytocin reduces hyperalgesia in mice: implication for cannabinoid and opioid systems. Peptides 38: 81-88.
46. Ryu PD, Gerber G, Murase K, Randic M, (1988). Calcitonin gene-related peptide enhances calcium current of rat dorsal root ganglion neurons and spinal excitatory synaptic transmission. Neurosci Lett 89: 305-312.
47. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ, (1995). Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 115: 1265-1275.
48. Schepers RJ, Mahoney JL, Gehrke BJ, Shippenberg TS, (2008). Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation. Pain 138: 423-439.
49. Seybold VS, Galeazza MT, Garry MG, Hargreaves KM, (1995). Plasticity of calcitonin gene related peptide neurotransmission in the spinal cord during peripheral inflammation. Can J Physiol Pharmacol 73: 1007-1014.
50. Shaqura MA, Zollner C, Mousa SA, Stein C, Schafer M, (2004). Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther 308: 712-718.
51. Simonin F, Kieffer BL, (2002). Two faces for an opioid peptide-and more receptors for pain research. Nat Neurosci 5: 185-186.
52. Snyder SH, (1992). Nitric oxide: first in a new class of neurotransmitters. Science 257: 494-496.
53. Stein C, Zollner C, (2009). Opioids and sensory nerves. Handb Exp Pharmacol 194: 495-518.
54. Su TF, Zhang LH, Peng M, Wu CH, Pan W, Tian B, et al. (2011). Cannabinoid CB2 receptors contribute to upregulation of beta-endorphin in inflamed skin tissues by electroacupuncture. Mol Pain 7: 98.
55. Sun RQ, Lawand NB, Willis WD, (2003). The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain 104: 201-208.
56. Viet CT, Schmidt BL, (2012). Biologic mechanisms of oral cancer pain and implications for clinical therapy. J Dent Res 91: 447-453.
57. Welch SP, Sim-Selley LJ, Selley DE, (2012). Sphingosine-1-phosphate receptors as emerging targets for treatment of pain. Biochem Pharmacol 84: 1551-1562.
58. Zeng J, Thomson LM, Aicher SA, Terman GW, (2006). Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats. J Neurosci 26: 12033-12042.
59. Zhang L, Taylor N, Xie Y, Ford R, Johnson J, Paulsen JE, et al. (2005). Cloning and expression of MRG receptors in macaque, mouse, and human. Brain Res Mol Brain Res 133: 187-197.
60. Zimmermann M, (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
61. Zylka MJ, Dong X, Southwell AL, Anderson DJ, (2003). Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc Natl Acad Sci U S A 100: 10043-10048.